Gastrin-releasing peptide: Difference between revisions
CSV import |
CSV import |
||
| Line 29: | Line 29: | ||
{{Peptide-stub}} | {{Peptide-stub}} | ||
{{Medicine-stub}} | {{Medicine-stub}} | ||
{{No image}} | |||
Revision as of 18:21, 10 February 2025
Gastrin-releasing peptide (GRP) is a neuropeptide that plays a crucial role in a variety of physiological and pathological processes. It is a 27-amino acid peptide that is primarily produced in the gastrointestinal tract and the central nervous system. GRP is known to stimulate the release of gastrin, a hormone that promotes the secretion of gastric acid in the stomach.
Function
Gastrin-releasing peptide functions as a neurotransmitter and a growth factor. It is involved in numerous physiological processes, including the regulation of gastric acid secretion, smooth muscle contraction, and cell proliferation. In the central nervous system, GRP acts as a neurotransmitter involved in pain transmission, thermoregulation, and circadian rhythms.
Structure
The structure of GRP is characterized by a 27-amino acid peptide chain. The peptide chain is synthesized as a larger precursor molecule, which is then cleaved to produce the active form of GRP. The active form of GRP is highly conserved across different species, indicating its important role in physiological processes.
Clinical significance
Abnormal levels of GRP have been associated with various diseases. Elevated levels of GRP have been found in certain types of cancer, including lung cancer, breast cancer, and prostate cancer. In these cancers, GRP acts as a growth factor, promoting the proliferation of cancer cells. In addition, GRP has been implicated in inflammatory bowel disease, where it is thought to contribute to inflammation and tissue damage.
Research
Research on GRP has focused on its role in disease and potential as a therapeutic target. Studies have investigated the use of GRP antagonists in the treatment of cancer and inflammatory diseases. In addition, research has explored the role of GRP in the central nervous system, with a focus on its potential involvement in neurological and psychiatric disorders.
See also
This peptide related article is a stub. You can help WikiMD by expanding it.
